TickerFacts.

Anika Therapeutics, Inc. (ANIK): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$5.68M
Year ended 2025-12-31
$500.0K
Trailing 12 months to 2026-06-30
$66.15M2009-12-31: $6.88M2010-12-31: $10.86M2011-12-31: $17.97M2012-12-31: $24.24M2013-12-31: $37.38M2014-12-31: $66.15M2015-12-31: $51.91M2016-12-31: $54.34M2017-12-31: $50.02M2018-12-31: $27.66M2019-12-31: $39.20M2020-12-31: -$22.24M2021-12-31: $9.10M2022-12-31: $10.37M2023-12-31: $7.28M2024-12-31: $1.78M2025-12-31: -$5.68M-$5.68M
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$5.68Mn/m2026-03-03, From 2025-01-01
2024-12-31$1.78M-75.5%2026-03-03, From 2024-01-01
2023-12-31$7.28M-29.8%2026-03-03, From 2023-01-01
2022-12-31$10.37M+14.1%2025-03-17, From 2022-01-01
2021-12-31$9.10Mn/m2024-03-15, From 2021-01-01
2020-12-31-$22.24Mn/m2023-03-16, From 2020-01-01
2019-12-31$39.20Mn/c2022-03-11, From 2019-01-01
2018-12-31$27.66M-44.7%2021-04-26, From 2018-01-01
2017-12-31$50.02M-8.0%2020-03-06, From 2017-01-01
2016-12-31$54.34M+4.7%2019-02-27, From 2016-01-01
2015-12-31$51.91M-21.5%2018-02-27, From 2015-01-01
2014-12-31$66.15M+77.0%2017-02-24, From 2014-01-01
2013-12-31$37.38M+54.2%2016-03-10, From 2013-01-01
2012-12-31$24.24M+34.9%2015-03-13, From 2012-01-01
2011-12-31$17.97M+65.5%2014-03-13, From 2011-01-01
2010-12-31$10.86M+57.8%2013-03-14, From 2010-01-01
2009-12-31$6.88Mn/a2012-03-13, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31-$5.68Mn/m
Orasure Technologies Inc (OSUR)2025-12-31-$61.78Mn/m
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30-$126.03Mn/m
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$12.51Mn/m
InfuSystem Holdings, Inc (INFU)2025-12-31$25.21M+30.0%
Neuronetics, Inc. (STIM)2025-12-31-$27.97Mn/m
Iradimed Corp (IRMD)2025-12-31$27.31M+19.9%
PRO DEX Inc (PDEX)2026-06-30$14.38M+20.6%
Sight Sciences, Inc. (SGHT)2025-12-31-$36.61Mn/m

Compare ANIK, OSUR, KMTS, XTNT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗